S. Feldman et al., 2-YEAR FOLLOW-UP OF 263 PATIENTS WITH POST PERIMENOPAUSAL VAGINAL BLEEDING AND NEGATIVE INITIAL BIOPSY, Gynecologic oncology, 55(1), 1994, pp. 56-59
Patients with post- or perimenopausal bleeding (PMB) whose initial end
ometrial biopsy or dilation and curettage (D&C) reveals benign or insu
fficient tissue may eventually be diagnosed with endometrial cancer or
complex endometrial hyperplasia. We studied 286 consecutive patients
with PMB who had either an endometrial biopsy or D&C at Brigham and Wo
men's Hospital during November 1990 to April 1991 and reviewed their s
ubsequent specimens after a minimum of 23 months of follow-up. Of the
initial 286 patients with PMB, 6 (2%) had endometrial cancer on their
index biopsy, 17 (6%) had complex hyperplasia, and 201 (70%) had other
benign findings. Sixty-two (22%) had ''tissue insufficient for diagno
sis.'' Excluding the 23 with cancer/complex hyperplasia, there were 26
3 patients in the cohort, 86 of whom (33%) had further endometrial sam
pling during the follow-up period. Of these, four (2%) were subsequent
ly found to have a uterine malignancy (2 of the benigns, 2 of the insu
fficients) and five (2%) were subsequently found to have complex hyper
plasia. Of the four patients subsequently found to have cancer, two ha
d stage I adenocarcinoma, one had stage IV adenocarcinoma, and one had
stage I high-grade stromal sarcoma. (C) 1994 Academic Press, Inc.